Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Irving TX, Nashville TN, Indianapolis IN, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07403721
Phase1, Recruiting
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
for
Advanced Malignant Solid Tumor, Solid Tumor Cancer
Location: Dallas TX, Houston TX, Los Angeles CA
Sponsor: Pilatus Biosciences Inc
Sex: All
Age: 18+
Code: NCT07337525
Phase1, Recruiting
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
for
Cancer, Cancer (Solid Tumors)
Location: Dallas TX, Huntersville NC, Fairfax VA
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07317505
Phase1, Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Dallas TX, San Antonio TX, Grand Rapids MI, Fairfax VA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07349537
Phase1, Recruiting
A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
for
Advanced-stage Solid Tumors
Location: Irving TX, Orlando FL
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07223125
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Fort Worth TX, Irving TX, Arlington TX, Red Oak TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase2, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Dallas TX, Houston TX, San Antonio TX, New Orleans LA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase1, Recruiting
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
for
Solid Tumor Malignancies
Location: Irving TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07207707
Phase1, Recruiting
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Los Angeles CA
Sponsor: CStone Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06741644
Phase1, Phase2, Recruiting
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
for
Advanced/Metastatic Colorectal Adenocarcinoma
Location: Irving TX
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT07535112
Phase1, Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Dallas TX, Fort Worth TX, Austin TX, Houston TX,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase1, Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Irving TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07488676
Phase1, Phase2, Recruiting
A Study of HS-20110 in Participants With Advanced Solid Tumors
for
Solid Tumors
Location: Irving TX, Houston TX, San Antonio TX, Fort Wayne IN,
Sponsor: Hansoh BioMedical R&D Company
Sex: All
Age: 18+
Code: NCT06892379
Phase1, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)